| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.32 | 3e-07 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.31 | 2e-06 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-06 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | 0.23 | 5e-05 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0006 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.19 | 0.0008 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |